413 related articles for article (PubMed ID: 16282217)
1. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
King JT; Tsevat J; Lave JR; Roberts MS
Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
[TBL] [Abstract][Full Text] [Related]
2. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis.
Byrne MM; O'malley K; Suarez-Almazor ME
Med Decis Making; 2005; 25(6):655-66. PubMed ID: 16282216
[TBL] [Abstract][Full Text] [Related]
3. When does quality-adjusting life-years matter in cost-effectiveness analysis?
Chapman RH; Berger M; Weinstein MC; Weeks JC; Goldie S; Neumann PJ
Health Econ; 2004 May; 13(5):429-36. PubMed ID: 15127423
[TBL] [Abstract][Full Text] [Related]
4. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
5. Willingness to pay for a QALY.
Gyrd-Hansen D
Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
[TBL] [Abstract][Full Text] [Related]
6. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
[TBL] [Abstract][Full Text] [Related]
7. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?
Shiroiwa T; Sung YK; Fukuda T; Lang HC; Bae SC; Tsutani K
Health Econ; 2010 Apr; 19(4):422-37. PubMed ID: 19382128
[TBL] [Abstract][Full Text] [Related]
8. Estimating a WTP-based value of a QALY: the 'chained' approach.
Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
[TBL] [Abstract][Full Text] [Related]
9. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
Franic DM; Bothe AK; Bramlett RE
J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
[TBL] [Abstract][Full Text] [Related]
10. Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey.
Franic DM; Pathak DS; Gafni A
J Clin Epidemiol; 2005 Mar; 58(3):291-303. PubMed ID: 15718119
[TBL] [Abstract][Full Text] [Related]
11. [Economic examination of the 2006/7 update of the Israeli national list of health services].
Shmueli A; Nissan-Englcin E
Harefuah; 2008 Jun; 147(6):488-92, 576. PubMed ID: 18693622
[TBL] [Abstract][Full Text] [Related]
12. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
[TBL] [Abstract][Full Text] [Related]
13. Willingness to pay for a quality-adjusted life-year: the individual perspective.
Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
[TBL] [Abstract][Full Text] [Related]
14. Can we estimate the 'social' value of a QALY? Four core issues to resolve.
Smith RD; Richardson J
Health Policy; 2005 Sep; 74(1):77-84. PubMed ID: 16098414
[TBL] [Abstract][Full Text] [Related]
15. [The burden of depressive disorders in Germany - results from the European Study of the Epidemiology of Mental Disorders (ESEMeD)].
Günther OH; Friemel S; Bernert S; Matschinger H; Angermeyer MC; König HH
Psychiatr Prax; 2007 Sep; 34(6):292-301. PubMed ID: 17806016
[TBL] [Abstract][Full Text] [Related]
16. A utility-theoretic model for QALYs and willingness to pay.
Klose T
Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
[TBL] [Abstract][Full Text] [Related]
17. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation.
Bobinac A; van Exel NJ; Rutten FF; Brouwer WB
J Health Econ; 2012 Jan; 31(1):158-68. PubMed ID: 22018622
[TBL] [Abstract][Full Text] [Related]
18. Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?
Pickard AS; Wang Z; Walton SM; Lee TA
Health Qual Life Outcomes; 2005 Mar; 3():11. PubMed ID: 15748287
[TBL] [Abstract][Full Text] [Related]
19. Disentangling WTP per QALY data: different analytical approaches, different answers.
Gyrd-Hansen D; Kjaer T
Health Econ; 2012 Mar; 21(3):222-37. PubMed ID: 21254305
[TBL] [Abstract][Full Text] [Related]
20. Relationship between utility values and willingness to pay in patients undergoing orthognathic treatment.
Cunningham SJ; Hunt NP
Community Dent Health; 2000 Jun; 17(2):92-6. PubMed ID: 11349993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
